logo
  • Home
  • News
Menu

Month: December 2024

Home / December 2024 ( / Page 233)
+

Crypto.com and Mastercard to Scale the Digital Payments Industry

04 Dec Crypto News

Crypto.com has secured a principal licence with Mastercard, enabling the company to directly issue cards on Mastercard’s network. Crypto.com…

UnitedHealthcare stock price jumps after CEO Brian Thompson was shot dead

04 Dec Stock Analysis

By ALICE WRIGHT FOR DAILYMAIL.COM Published: 04:51 AEDT, 5 December 2024 | Updated: 09:35 AEDT, 5 December 2024 UnitedHealthcare…

+

This Week in Web3: A Crypto-Friendly SEC

04 Dec Crypto News

Cryptocurrency may have started as a rebel yell against traditional finance, but its future is increasingly converging with it….

+

No, Rocket Lab Stock Does Not Defy Gravity (Technical Analysis)

04 Dec Stock Analysis

This article was written by Follow I’m a technically-oriented Canadian investor with a focus on U.S. markets, particularly in…

+

The Crypto Plan to Turn $20 Into $20,000 During This Bull Market Surge!

04 Dec Crypto News

SPONSORED POST* As the crypto market experiences a surge, there’s a buzz about small investments turning into substantial sums….

+

pharma giant’s stock poised for growth amid challenges By Investing.com

04 Dec Stock Analysis

AstraZeneca PLC (NASDAQ:LON:), a global biopharmaceutical powerhouse, has been making significant strides in the pharmaceutical industry, particularly in the…

+

Trump announces crypto-friendly Paul Atkins to head the SEC

04 Dec Crypto News

President-elect Donald Trump just tapped a crypto-friendly face to chair the Securities and Exchange Commission, fulfilling…

+

NVST Factor-Based Stock Analysis – Benjamin Graham

04 Dec Stock Analysis

Below is Validea’s guru fundamental report for ENVISTA HOLDINGS CORP (NVST). Of the 22 guru strategies we follow, NVST…

+

Crypto Update: UK Government Outlines Its Approach to Digital Asset Regulation | Skadden, Arps, Slate, Meagher & Flom LLP

04 Dec Crypto News

In her first comments since the July 2024 UK general election, Economic Secretary to the UK…

+

pemvidutide’s potential reshapes obesity and NASH stock outlook By Investing.com

04 Dec Stock Analysis

Altimmune, Inc. (NASDAQ:), a clinical-stage biopharmaceutical company, has been making waves in the obesity and liver disease treatment landscape…

Prev 1 … 232 233 234 … 306 Next

recent post

  • 108224456-251111_cw_thumbnail.jpg

    Gemini shares sink after reporting wider-than-expected

    Nov 11 2025
  • 0902-Q1920Total20Markets20photos20and20gif_CC8.jpg

    Coca-Cola’s Premium Price Tag: Is the

    Nov 11 2025
  • 0a6f662ed688635193a656c7414b485b.jpeg

    China Accuses US Of $13 Billion

    Nov 11 2025
  • 2059525054-d471e5dd757af97f82f6a1e2f65ebdaedfd20289840aef893df606ec76a7c99d-d_1280.jpeg

    How Joe Albano Uses Seeking Alpha

    Nov 11 2025
  • GettyImages-2225854733.jpg

    Shares of Winklevoss’s Gemini sag as

    Nov 11 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.